top of page

Moderna’s Head of R&D explains how mRNA is being tested with other emerging cancer modalities

Stephen Hoge explains how Moderna is partnering on programs that include CAR-T, TCRs, bi-specifics, and in-vivo editing programs.



Commentaires


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page